Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Wall Street’s Most Accurate Analysts Say Buy These 3 Utilities Stocks With Over 3% Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often…
byAvi Kapoor
May 2, 2024
2 minute read
Total
0
Shares
0
0
0
0
0
0

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga’s extensive database of analyst ratings, including by analyst accuracy .

Below are the ratings of the most accurate analysts for three high-yielding stocks in the utilities sector.

CMS Energy Corporation (NYSE:CMS)

  • Dividend Yield: 3.39%
  • BMO Capital analyst James Thalacker maintained an Outperform rating and increased the price target from $67 to $68 on April 26. This analyst has an accuracy rate of 64%.
  • JP Morgan analyst Richard Sunderland maintained an Overweight rating and raised the price target from $65 to $66 on March 13. This analyst has an accuracy rate of 64%.
  • Recent News: On April 25, CMS Energy posted better-than-expected quarterly earnings.

Sempra (NYSE:SRE)

  • Dividend Yield: 3.45%
  • Barclays analyst Eric Beaumontmaintained an Overweight rating and increased the price target from $77 to $79 on March 14. This analyst has an accuracy rate of 70%.
  • RBC Capital analyst Shelby Tucker reiterated an Outperform rating with a price target of $82 on March 6. This analyst has an accuracy rate of 62%.
  • Recent News: Sempra is expected to release its first-quarter 2024 earnings on Tuesday, May 7.

PPL Corporation (NYSE:PPL)

  • Dividend Yield: 3.68%
  • B of A Securities analyst Julien Dumoulin-Smithmaintained a Buy rating and raised the price target from $29 to $30 on April 11. This analyst has an accuracy rate of 68%.
  • RBC Capital analyst Shelby Tucker maintained an Outperform rating and boosted the price target from $30 to $31 on April 11. This analyst has an accuracy rate of 62%.
  • Recent News: On May 1, PPL posted better-than-expected quarterly earnings.

Read More: Apple, Kellanova And 3 Stocks To Watch Heading Into Thursday

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Older Patients Are Choosing Cannabis To Treat Chronic Pain, Arthritis, Anxiety And Insomnia, New Study Shows

By Jelena Martinovic
April 3, 11:12 AM
Older patients comprise a growing subset of medical cannabis patients, according to a new study. Titled Age-related Patterns of Medical Cannabis Use: A Survey of Authorized Patients in Canada, the new scientific publication presented the consumption trends observed in patients and the self-reported impacts of medical cannabis in alleviating the patients' primary symptoms. Tilray Medical, a division of Tilray Brands, Inc. is behind the study which is derived from the Canadian Cannabis Patient Survey (CCPS) 2021, which included 2,697 patients. The researchers focused primarily on older patients with a mean age of 54.3. Patients with chronic pain (27.8%), arthritis (14.9%) and anxiety (9%) were the most numerous among those seeking cannabis to treat their primary illnesses. Pain was the most common primary symptom for which patients use medical cannabis, followed by anxiety and insomnia/sleep disorder.

TLRY